Sfoglia per Rivista ALIMENTARY PHARMACOLOGY
C-13-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation
2004-01-01 Candelli, M; Armuzzi, A; Nista, Ec; Fini, L; Gasbarrini, G; Gasbarrini, A
Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn's ileal disease
2005-01-01 Laghi, L.; Costa, S.; Saibeni, S.; Bianchi, P.; Omodei, P.; Carrara, A.; Spina, L.; Contessini Avesani, E.; Vecchi, M.; De Franchis, R.; Malesci, A.
CCK-1 receptor blockade for treatment of biliary colic: a pilot study
2003-01-01 Malesci, A.; Pezzilli, R.; D'Amato, M.; Rovati, L.
Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study
2006-01-01 Andriani, A; Zullo, A; Di Raimondo, F; Patti, C; Tedeschi, Luigi; Recine, U; Caruso, L; Bonanno, George; Chiarenza, A; Lizzani, G; Miedico, A; Romanelli, A; Costa, Antonio; Linea, C; Marrone, C; Mirto, S; Mistretta, A; Montalbano, L; Restivo, G; Vinci, Maria Rosaria; Bibas, M; Hassan, Cesare; Stella, Federico; Cottone, M; Morini, S.
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST
2024-01-01 Peyrin‐biroulet, Laurent; Vermeire, Séverine; D'Haens, Geert; Panés, Julian; Dignass, Axel; Magro, Fernando; Nazar, Maciej; Le , ; Bars, Manuela; Lahaye, Marjolein; Ni, Lioudmila; Bravatà, Ivana; Lavie, Frederic; Daperno, Marco; Lukáš, Milan; Armuzzi, Alessandro; Löwenberg, Mark; Gaya, Daniel R.; Danese, Silvio
Commentary : Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C
2013-01-01 Aghemo, A.; Lampertico, P.
Commentary: adjunct antibiotic combination therapy for ulcerative colitis - is it time to investigate Fusobacterium varium?
2014-01-01 Fiorino, G; Danese, S
Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation.
2014-01-01 Fiorino, G; Allocca, M; Danese, S.
Commentary: antibodies reacting with the infliximab Fab portion - something new?
2013-01-01 Allocca, M; Fiorino, G; Danese, S
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome
2013-01-01 Jovani, M; Fiorino, G; Danese, S
Commentary: low-volume bowel preparation for colonoscopy - authors' reply
2012-01-01 Repici, A; Hassan, C
Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease
2020-01-01 Daude, Sébastien; Remen, Thomas; Chateau, Thomas; Danese, Silvio; Gastin, Isabelle; Baumann, Cédric; Gueant, Jean Louis; Peyrin-Biroulet, Laurent
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer
1998-01-01 Savarino, V.; Mela, G. S.; Zentilin, P.; Bisso, G.; Pivari, M.; Vigneri, S.; Termini, R.; Fiorucci, S.; Usai, P.; Malesci, A.; Celle, G.
Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C
2006-01-01 Borroni, G.; Ceriani, R.; Cazzaniga, M.; Tommasini, M.; Roncalli, M.; Maltempo, C.; Felline, C.; Salerno, F.
Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group.
1999-01-01 Annese, V; Bassotti, G; Coccia, G; D'Onofrio, V; Gatto, G; Repici, A; Andriulli, A.
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients
2019-01-01 Pouillon, L; Danese, S; Hart, A; Fiorino, G; Argollo, M; Selmi, C; Carlo Stella, C; Loeuille, D; Costanzo, A; Lopez, A; Vegni, E; Radice, S; Gilardi, D; Socha, M; Fazio, M; Gonzalez-Lorenzo, M; Bonovas, S; Magro, F; Peyrin-Biroulet, L
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply
2018-01-01 Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S
Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non‐elderly patients with inflammatory bowel disease—the IG‐IBD LIVE study. Authors' reply
2022-01-01 Pugliese, Daniela; Privitera, Giuseppe; Armuzzi, Alessandro
Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply
2017-01-01 Bonovas, S; Fiorino, G; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease
2014-01-01 Cesarini, M; Danese, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile